Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Strategic Planning > Three Critical Business Plan Perspectives

Tags

  • devices
  • patients
  • product
  • combination products
  • companies involved

  • Links

  • Why You Need a Lender to Sell Your Home
  • Canna Lily Sales Face a Chaotic Future
  • Brief Explanation of Digital Signal Processing, Compression, Encryption, and File Translation
  • Digg It - Three Critical Business Plan Perspectives

    A business plan presents an interpretation of differing perspectives. Three are critical to creating a business vision. These views form around typical worldvie
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ws. They are the future, past and present.

    The future is the most challenging view of the three. A business plan provides a blue print of our vision of the fut
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ure. We look into our crystal ball and make many choices about what the world will be like, what it will need and how we fit into that environment. The business
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    plan we create is the embodiment of the vision and a measurement stick of our progress as the future becomes the present. A plan documents our desired outcomes
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    and helps us measure our performance against it. Changing our business, or our business plans, to incorporate reality then eliminates deviations.

    Next we look a
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    t the past. We are reviewing what has happened in our industry, the world and in other businesses similar to ours. We use this look to formulate our business fu
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ture. How well we research and accurately interpret the past has a great impact on the reality our business plan will incorporate.

    Finally, we have the present.
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    This is our present operating environment. Our business plan foretold what resources our company would need and how they would be utilized to produce our marke
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    table goods or services. A plan done correctly identifies suppliers, sources of funding and the other resources necessary to accomplish the business vision. The
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    present reality is the measure of our predictions and the reality of the implementation of the business plan. If our operations closely agree with the plan, all
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    is going well. If there are substantial variations, we must address them and correct our business progress to move toward our business goals. Thus, the present
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    represents the actualization of the theoretical business plan. The present demonstrates how well we did in planning and predicting the business circumstances.

    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    An overlooked use for the business plan is the marketing use when approaching suppliers and those from which we need resources to be extended to the business. Ou
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    r business plan can be used to show the thought process and business plan. It can be used to convince resource suppliers we are a good risk and an opportunity to
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    establish a new and important business client. Too, employees should be familiar with the business plan in as much detail as can be useful to them in helping to
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    accomplish the business mission.

    These three perspectives are very important to all business plans. In fact, a small business needs a business plan worse than
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    a large one because of resources. Normally, large businesses tend to have sources of financing that can bridge problems until they can be corrected. Unfortunate
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ly, small businesses usually don't have the same deep pockets so the risk of unforeseen circumstances or problems is exaggerated significantly. True too, small b
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    usinesses tend to either fail to create a business plan or ignore them once they become involved in daily operations. Actually, this is when they need the plans
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    the most because of their inherent comparison and grading of reality against the proposed. But, all businesses do much better if they have plans and follow them.


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/44269/diggit-Three-Critical-Business-Plan-Perspectives.html">Three Critical Business Plan Perspectives</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/44269/diggit-Three-Critical-Business-Plan-Perspectives.html]Three Critical Business Plan Perspectives[/url]

    Related Articles:

    Customer Service at Home Depot and Lowes

    Stand Out in Networking Circles By Becoming a Subject Matter Expert

    Writing A Teacher Cover Letter That's In A Class Of Its Own

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com